117 related articles for article (PubMed ID: 30405840)
1. Survival analysis for lung adenosquamous carcinoma patients with brain metastasis.
Pan F; Cui S; Wang W; Gu A; Jiang L
J Cancer; 2018; 9(20):3707-3712. PubMed ID: 30405840
[No Abstract] [Full Text] [Related]
2. Time taken for a primary tumor to metastasize to the brain and the overall survival of patients with brain metastasis: An analysis of outcomes and factors affecting survival.
Hao P; Chen L; Ge Y; You Y; Yan G; Jin ZW
Technol Health Care; 2022; 30(S1):259-270. PubMed ID: 35124603
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
Sauvageot S; Mollevi C; Thomas QD; Charissoux M; Darlix A; Rigau V; Bauchet L; Quantin X; Pujol JL; Roch B; Boetto J
J Neurosurg; 2024 Jan; ():1-11. PubMed ID: 38241682
[TBL] [Abstract][Full Text] [Related]
4. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
5. The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
Chang WY; Wu YL; Su PL; Yang SC; Lin CC; Su WC
PLoS One; 2018; 13(2):e0192161. PubMed ID: 29447182
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
7. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
[TBL] [Abstract][Full Text] [Related]
8. Management and Outcomes of Newly Diagnosed Non-Small Cell Lung Cancer Patients with Brain Metastases: A Real-World Study in Japan.
Yoshida H; Kim YH; Iwatsubo S; Sakaguchi C; Sakamori Y; Nagai H; Ozasa H; Mio T; Hirai T
Oncology; 2020; 98(7):460-467. PubMed ID: 32222702
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
[TBL] [Abstract][Full Text] [Related]
10. Metastatic pattern and prognosis in patients with lung adenosquamous carcinoma: A surveillance, epidemiology, and end results-based population study.
Xie J; Li C
Heliyon; 2024 May; 10(9):e30641. PubMed ID: 38765098
[TBL] [Abstract][Full Text] [Related]
11. Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma.
Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
J Neurooncol; 2016 Oct; 130(1):221-228. PubMed ID: 27538910
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Experience with First-generation Epidermal Growth Factor Receptor
Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients
with Brain Metastasis].
Dong H; Cui S; Pan F; Dong L; Niu Y; Zhao Y; Gu A; Jin X; Jiang L
Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):114-123. PubMed ID: 28228223
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and prognosis of renal cell carcinoma patients with bone metastases].
Zhai JP; Liu N; Wang H; Wang HD; Man LB
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(14):1068-1071. PubMed ID: 32294868
[No Abstract] [Full Text] [Related]
14. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
[TBL] [Abstract][Full Text] [Related]
15. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for brain metastases in locally advanced non-small cell lung cancer patients treated with radical radiotherapy.
Xu X; Chen G; Fan S; Zhang Q; Huang W; Chen J; Ji W; Ma J; He J
J Thorac Dis; 2024 Jan; 16(1):479-490. PubMed ID: 38410550
[TBL] [Abstract][Full Text] [Related]
17. Bone metastasis predicts poor prognosis of patients with brain metastases from colorectal carcinoma post aggressive treatment.
Duan H; He ZQ; Guo CC; Li JH; Wang J; Zhu Z; Sai K; Chen ZP; Jiang XB; Mou YG
Cancer Manag Res; 2018; 10():2467-2474. PubMed ID: 30122996
[TBL] [Abstract][Full Text] [Related]
18. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs.
Gui Q; Liu J; Li D; Xu C
World J Surg Oncol; 2017 Oct; 15(1):184. PubMed ID: 29037198
[TBL] [Abstract][Full Text] [Related]
19. Primary esophageal adenosquamous carcinoma: a retrospective analysis of 24 cases.
Zhang HD; Chen CG; Gao YY; Ma Z; Tang P; Duan XF; Ren P; Yue J; Yu ZT
Dis Esophagus; 2014; 27(8):783-9. PubMed ID: 24127755
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study.
Bjørnhart B; Hansen KH; Jørgensen TL; Herrstedt J; Schytte T
Acta Oncol; 2019 Jul; 58(7):953-961. PubMed ID: 31081424
[No Abstract] [Full Text] [Related]
[Next] [New Search]
